These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 22920946
1. Copper levels in patients with hematological malignancies. Kaiafa GD, Saouli Z, Diamantidis MD, Kontoninas Z, Voulgaridou V, Raptaki M, Arampatzi S, Chatzidimitriou M, Perifanis V. Eur J Intern Med; 2012 Dec; 23(8):738-41. PubMed ID: 22920946 [Abstract] [Full Text] [Related]
2. Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels. Rivkina A, Vitols G, Murovska M, Lejniece S. Exp Oncol; 2011 Jun; 33(2):99-103. PubMed ID: 21716207 [Abstract] [Full Text] [Related]
3. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia. Saka B, Aktan M, Sami U, Oner D, Sanem O, Dinçol G. Clin Lab Haematol; 2006 Feb; 28(1):30-5. PubMed ID: 16430457 [Abstract] [Full Text] [Related]
4. FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia. Nückel H, Collins CH, Frey UH, Sellmann L, Dürig J, Siffert W, Dührsen U. Eur J Haematol; 2009 Dec 01; 83(6):541-9. PubMed ID: 19682311 [Abstract] [Full Text] [Related]
5. Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice. Doubek M, Mayer J, Obrtlíková P, Smolej L, Cmunt E, Schwarz J, Brejcha M, Kozmon P, Pospíšilová S, Brychtová Y, Pospíšil Z, Trněný M. Eur J Haematol; 2011 Aug 01; 87(2):130-7. PubMed ID: 21535162 [Abstract] [Full Text] [Related]
6. Carbonyl group serum levels are associated with CD38 expression in patients with B chronic lymphocytic leukemia. Musolino C, Allegra A, Alonci A, Saija A, Russo S, Cannavò A, Cristani M, Centorrino R, Saitta S, Alibrandi A, Gangemi S. Clin Biochem; 2011 Dec 01; 44(17-18):1487-90. PubMed ID: 21945028 [Abstract] [Full Text] [Related]
7. Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia. Molica S, Digiesi G, Battaglia C, Cutrona G, Antenucci A, Molica M, Giannarelli D, Sperduti I, Gentile M, Morabito F, Ferrarini M. Eur J Haematol; 2010 Oct 01; 85(4):314-20. PubMed ID: 20546021 [Abstract] [Full Text] [Related]
8. Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progression. Matthews C, Catherwood MA, Morris TC, Kettle PJ, Drake MB, Gilmore WS, Alexander HD. Eur J Haematol; 2006 Oct 01; 77(4):309-17. PubMed ID: 16856923 [Abstract] [Full Text] [Related]
13. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia. Ertault-Daneshpouy M, Noguera ME, Gisselbrecht C, Haddad A, Brice P, Marolleau JP, Soulier J, Mounier N. Clin Adv Hematol Oncol; 2008 Jan 01; 6(1):55-63. PubMed ID: 18322442 [Abstract] [Full Text] [Related]
14. A single tube, four-color flow cytometry assay for evaluation of ZAP-70 and CD38 expression in chronic lymphocytic leukemia. Hassanein NM, Perkinson KR, Alcancia F, Goodman BK, Weinberg JB, Lagoo AS. Am J Clin Pathol; 2010 May 01; 133(5):708-17. PubMed ID: 20395517 [Abstract] [Full Text] [Related]
15. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70). Schade U, Bock O, Vornhusen S, Jäger A, Büsche G, Lehmann U, Kreipe H. Hum Pathol; 2006 Sep 01; 37(9):1153-61. PubMed ID: 16938520 [Abstract] [Full Text] [Related]
16. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Schroers R, Griesinger F, Trümper L, Haase D, Kulle B, Klein-Hitpass L, Sellmann L, Dührsen U, Dürig J. Leukemia; 2005 May 01; 19(5):750-8. PubMed ID: 15759031 [Abstract] [Full Text] [Related]
17. Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia. Del Giudice I, Morilla A, Osuji N, Matutes E, Morilla R, Burford A, Maravelaki S, Owusu-Ankomah K, Swansbury J, A'Hern R, Brito-Babapulle V, Catovsky D. Cancer; 2005 Nov 15; 104(10):2124-32. PubMed ID: 16211545 [Abstract] [Full Text] [Related]
18. Significant change in ZAP-70 expression during the course of chronic lymphocytic leukemia. Vroblova V, Vrbacky F, Hrudkova M, Jankovicova K, Schmitzova D, Maly J, Krejsek J, Smolej L. Eur J Haematol; 2010 Jun 15; 84(6):513-7. PubMed ID: 20132303 [Abstract] [Full Text] [Related]